Taken together, the data from TMA IHC and scRNA-Seq suggest that the PI3K signaling pathway, particularly marked by the elevation of p-RPS6, correlates with disease progression in CRC patient samples. The gene discussed is PIK3CA; the disease is colorectal carcinoma.